Patent application number | Description | Published |
20080214620 | NOVEL INHIBITORS OF GLUTAMINYL CYCLASE - The present invention relates to compounds of formula (I), combinations and uses thereof for disease therapy, | 09-04-2008 |
20080234313 | NOVEL INHIBITORS - Compounds of formula (I), combinations and uses thereof for disease therapy, | 09-25-2008 |
20110092501 | NOVEL INHIBITORS - The invention relates to novel pyrrolidine derivatives of formula (I): | 04-21-2011 |
20110224259 | NOVEL INHIBITORS - The invention relates to novel heterocyclic derivatives as inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5). QC catalyzes the intramolecular cyclization of N-terminal glutamine residues into pyroglutamic acid (5-oxo-prolyl, pGlu*) under liberation of ammonia and the intramolecular cyclization of N-terminal glutamate residues into pyroglutamic acid under liberation of water. | 09-15-2011 |
20110262388 | NOVEL INHIBITORS - Novel heterocyclic derivatives as inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5). QC catalyzes the intramolecular cyclization of N-terminal glutamine residues into pyroglutamic acid (5-oxo-prolyl, pGlu*) under liberation of ammonia and the intramolecular cyclization of N-terminal glutamate residues into pyroglutamic acid under liberation of water. | 10-27-2011 |
20120237475 | Novel Inhibitors - Novel heterocyclic derivatives of formula (I): | 09-20-2012 |
20120301398 | RADIOLABELLED GLUTAMINYL CYCLASE (QC) INHIBITORS AND USES OF SAME - Radiolabeled glutaminylcyclase (QC) inhibitors as imaging agents, in particular, but not exclusively, as medical imaging agents for the detection of neurological disorders; and pharmaceutical compositions, methods and kits for detecting neurological disorders, using the radiolabeled inhibitors. | 11-29-2012 |
20140065095 | NOVEL INHIBITORS - The invention relates to novel pyrrolidine derivatives of formula (I): | 03-06-2014 |